GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now emerging as a prominent focus in medical studies, largely due to its remarkable impact on treating conditions such as second type diabetes and excess body fat. Ongoing research have shown that in addition to glucose regulation, GLP-1 agonists offer potential for cardiovascular healt